onr:"swepub:oai:DiVA.org:umu-35458"
Search: onr:"swepub:oai:DiVA.org:umu-35458" > Methylation profile...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Barekati, Zeinab (author)
Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
- Article/chapterEnglish2010
Publisher, publication year, extent ...
- 2010-05-12
- Oxford Journals,2010
- printrdacarrier
Numbers
- LIBRIS-ID:oai:DiVA.org:umu-35458
- https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-35458URI
- https://doi.org/10.1093/hmg/ddq199DOI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- The present study investigated promoter hypermethylation of TP53 regulatory pathways providing a potential link between epigenetic changes and mitochondrial DNA (mtDNA) alterations in breast cancer patients lacking a TP53 mutation. The possibility of using the cancer-specific alterations in serum samples as a blood-based test was also explored. Triple-matched samples (cancerous tissues, matched adjacent normal tissues and serum samples) from breast cancer patients were screened for TP53 mutations, and the promoter methylation profile of P14(ARF), MDM2, TP53 and PTEN genes was analyzed as well as mtDNA alterations, including D-loop mutations and mtDNA content. In the studied cohort, no mutation was found in TP53 (DNA-binding domain). Comparison of P14(ARF) and PTEN methylation patterns showed significant hypermethylation levels in tumor tissues (P < 0.05 and <0.01, respectively) whereas the TP53 tumor suppressor gene was not hypermethylated (P < 0.511). The proportion of PTEN methylation was significantly higher in serum than in the normal tissues and it has a significant correlation to tumor tissues (P < 0.05). mtDNA analysis revealed 36.36% somatic and 90.91% germline mutations in the D-loop region and also significant mtDNA depletion in tumor tissues (P < 0.01). In addition, the mtDNA content in matched serum was significantly lower than in the normal tissues (P < 0.05). These data can provide an insight into the management of a therapeutic approach based on the reversal of epigenetic silencing of the crucial genes involved in regulatory pathways of the tumor suppressor TP53. Additionally, release of significant aberrant methylated PTEN in matched serum samples might represent a promising biomarker for breast cancer.
Subject headings and genre
- MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Cancer och onkologi hsv//swe
- MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology hsv//eng
- Oncology
- Onkologi
Added entries (persons, corporate bodies, meetings, titles ...)
- Radpour, Ramin (author)
- Kohler, Corina (author)
- Zhang, Bei (author)
- Toniolo, Paolo (author)
- Lenner, PerUmeå universitet,Onkologi(Swepub:umu)pele0005 (author)
- Lv, Qing (author)
- Zheng, Hong (author)
- Zhong, Xiao Yan (author)
- Umeå universitetOnkologi (creator_code:org_t)
Related titles
- In:Human Molecular Genetics: Oxford Journals19:15, s. 2936-29460964-69061460-2083
Internet link
Find in a library
- Human Molecular Genetics (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Barekati, Zeinab
- Radpour, Ramin
- Kohler, Corina
- Zhang, Bei
- Toniolo, Paolo
- Lenner, Per
- show more...
- Lv, Qing
- Zheng, Hong
- Zhong, Xiao Yan
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Cancer and Oncol ...
- Articles in the publication
- Human Molecular ...
- By the university
- Umeå University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
